ImmunoDiagnostics

ImmunoDiagnostics is a Hong Kong-based spin-off biotechnology company from The University of Hong Kong focused on biomarker discovery, assay development, and in vitro diagnostics for chronic and infectious diseases. The company develops and markets diagnostic and research products including ELISA kits, PETIA kits, immunoblot strips, recombinant proteins, and monoclonal and polyclonal antibodies. Its main disease focus includes cardiometabolic, autoimmune, and infectious diseases, with additional assay services for academic, clinical, pharmaceutical, and biotech customers. ImmunoDiagnostics also built COVID-19 diagnostic products and has distributed certain COVID-19 assays internationally. The company appears to operate as a commercial diagnostics and research-tools supplier rather than a therapeutic drug developer.